Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-017966
Filing Date
2014-12-11
Accepted
2014-12-11 16:17:55
Documents
1
Period of Report
2014-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5464
  Complete submission text file 0001179110-14-017966.txt   7024
Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP ONE KENDALL SQUARE, STE B14402 CAMBRIDGE MA 02139
Business Address
PERRIN MARK D (Reporting) CIK: 0001250085 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 141280975

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus